Research Use Only. Not medical advice. Evidence is route and indication dependent. IV NAD+ administration requires clinical setting.
NAD+ Protocol Reference
Joseph physician practice SC protocol, cycle structure, and longevity stack pairing context.
Sourced Protocol Frameworks
Source: Joseph Physician Practice ProtocolProtocol philosophy: SC route for longevity context. Start 50 mg and assess before escalating. IV use requires clinical setting and rate titration.
START50 mg SC daily, 5 days/week. Joseph starting point for longevity context. Allow tolerance assessment before escalation.
TARGET100 mg SC daily, 5 days/week. Joseph target range as tolerated.
IV CONTEXTIV at higher doses used in physician practice for energy and addiction contexts — requires clinical setting. Rate titration is critical to avoid chest tightness and nausea.
Reconstitution Reference
Calculation Example — 500 mg Vial
VIAL CONTENT
500 mg
DILUENT
Sterile water or saline (formulation-dependent)
EXAMPLE VOLUME
5.0 mL
CONCENTRATION
100 mg/mL
50 mg DOSE
0.5 mL = 50 units U-100
STORAGE
Refrigerated 4°C, protect from light
⚠ Arithmetic example only. No universal standard. Actual preparation depends on specific vial strength and formulation.
Cycle & Reassessment
| Parameter | Framework | Source |
|---|---|---|
| Typical cycle | 8–12 weeks SC; extended use in chronic contexts | Joseph practice |
| Long-term | Some longer use described — individualized | Joseph practice |
| Reassessment | After 8–12 weeks of regular use | Protocol philosophy |
Pairing & Sequencing
| Compound | Relationship | Sequencing |
|---|---|---|
| SS-31 | Mitochondrial foundation pairing | Concurrent — complementary mechanisms |
| MOTS-c | AMPK/metabolic signaling + energy | Concurrent — Joseph longevity stack |
| Epitalon | Aging/circadian research | Concurrent in longevity protocols |
Evidence Status
| Category | Status |
|---|---|
| Overall | Clinical/practice use — evidence route-dependent |
| Human data | Multiple small trials; IV use in addiction/fatigue documented |
| FDA status | Not approved as drug; oral precursors available as supplements |
| WADA status | Not prohibited (verify current list) |
Source NAD+ at Forge Scientific
Third-party tested, HPLC + Mass Spec verified, lot-specific COA. Ships same day — Fort Worth, TX.